septum during percutaneous mitral balloon valvuloplasty (PMBV) (2) . We attributed the thrombus formation to the damage to interatrial septum during septostomy and no anticoagulation with UFH before septostomy in patients with AF. Despite severe mitral regurgitation (MR) reducing left atrial spontaneous echo contrast (LASEC) and thrombus formation in left atrium due to jet flow (3), we considered that reduced MR by MitraClip does not have an influence on thrombus formation, at least, in acute period in these cases. Patients with AF who were not anticoagulated until septostomy may develop LASEC and thrombus by virtue of mechanical trauma during septostomy. There is a case report in literature regarding a patient without AF having developed large thrombus in left atrial posterolateral wall after 5 days of MitraClip procedure because the patient was not administered UFH (4). We consider that mechanical trauma and possibly lack of anticoagulation before septostomy may have resulted in thrombus formation in the region of septal puncture as Bilge et al. (1) stated.
Administration of UFH during septostomy in PMBV procedure, as in MitraClip procedure, is an increasingly debated issue. Application of UFH at the beginning of PMBV procedure diminishes embolic complications; meanwhile, it is associated with increased risk of bleeding and length of hospital stay. However, cases that developed thrombus following UFH administration after septostomy have also been observed (5).
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